Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-06

Clinical Trial Update: Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on pirfenidone combined with M-DDO gel for acne vulgaris, including superficial, mixed comedonal and inflammatory subtypes, across Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • M-DDO gel (M-DDO gel)
  • PIRFENIDONE (pirfenidone)

Snippet

Sponsor: University of Guadalajara | Conditions: Acne Vulgaris Superficial Mixed Comedonal and Inflammatory | Phase 1, Phase 2 | Status: COMPLETED